drugset / Trial / NCT05383625

Gardasil Versus Cervarix in the Treatment of Warts

NCT05383625

Phase 3 Completed 50 enrolled Zagazig University
RandomizedParallel-groupDouble-blindTreatment

Summary

Warts are common, benign, epidermal proliferations caused by HPV infecting skin and mucous membranes. Treatment of warts poses a true challenge despite existing variable therapeutic modalities, whether destructive or immunotherapeutic. Human papilloma virus (HPV) vaccines are FDA approved for the prevention of genital warts and wart related precancerous and cancerous lesions but they are not indicated for treatment of preexisting warts yet

Timeline

Start
2020-09-01
Primary completion
2021-10-01
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bivalent Human Papilloma Virus Vaccine Vaccine 0.1 ml Other
Subject Gardasil Vaccine 0.1 ml Other

Indications